复发性乳房植入物相关间变性大细胞淋巴瘤表现为难治性积液且FDG PET/CT低摄取
Relapsed Breast Implant-Associated Anaplastic Large-Cell Lymphoma Presenting as Refractory Fluid Collections With Low Uptake on FDG PET/CT Scan.
PubMed 文献 · Clin Nucl Med · 2021-01-01
本文报道一例45岁女性复发性乳房植入物相关间变性大细胞淋巴瘤(BIA-ALCL),表现为难治性积液,尽管细胞学确诊,FDG PET/CT却显示低摄取。BIA-ALCL通常发生于纹理面乳房植入物放置多年后,患者常因疼痛、可触及肿块或肿胀就诊,但本例影像表现不典型。
要点
- BIA-ALCL可表现为难治性积液,FDG PET/CT低摄取不排除诊断。
- 细胞学检查对确诊BIA-ALCL至关重要,尤其影像不典型时。
- 纹理面乳房植入物史是BIA-ALCL的重要危险因素,需长期随访。
核心结论
- 复发性BIA-ALCL可表现为难治性积液,且FDG PET/CT呈低摄取,细胞学确诊可避免漏诊。
研究设计与样本
- 个案报道,描述一例45岁女性复发性乳房植入物相关间变性大细胞淋巴瘤的临床表现与影像学特征。
主要发现
- 患者表现为难治性积液,FDG PET/CT显示低摄取,但细胞学检查确诊为复发性BIA-ALCL。
临床怎么用
- 对乳房植入物患者出现难治性积液时,即使FDG PET/CT低摄取,也应行细胞学检查以排除BIA-ALCL。
局限性
- 个案报道,结论不能推广至所有BIA-ALCL患者;原文未报告长期随访或治疗结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Breast implant-associated anaplastic large-cell lymphoma is a rare type of non-Hodgkin lymphoma that occurs years after placement of textured surface breast implants. Patients typically present after the development of pain, a palpable mass, or swelling. We present a case of a 45-year-old woman with recurrent breast implant-associated anaplastic large-cell lymphoma presenting as refractory fluid collections, and the unusual finding of low uptake on FDG PET/CT scan despite being confirmed by cytology.
来源:Clin Nucl Med,查看原文。版权归原作者所有。
引用
- Alsa'di HS, Donald JS. Relapsed Breast Implant-Associated Anaplastic Large-Cell Lymphoma Presenting as Refractory Fluid Collections With Low Uptake on FDG PET/CT Scan. Clin Nucl Med. 2021. PMID: 34132681. doi:10.1097/RLU.0000000000003766
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。